WallStSmart
INGN

Inogen Inc

NASDAQ: INGN · HEALTHCARE · MEDICAL DEVICES

$7.11
+1.57% today

Updated 2026-04-30

Market cap
$197.44M
P/E ratio
P/S ratio
0.57x
EPS (TTM)
$-0.86
Dividend yield
52W range
$5 – $9
Volume
0.3M

Inogen Inc (INGN) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+40.3%
Last 4 quarters
Revenue YoY growth
+2.0%
Most recent quarter
EPS YoY growth
+37.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-5.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-12.8%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-03$-0.15+56.2%$6.18$6.31+2.1%
2025-11-05$-0.20+4.8%$8.06$7.03-12.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.34$-0.15+56.2%$81.72M+2.0%
2025-09-30$-0.21$-0.20+4.8%$92.39M+4.0%
2025-06-30$-0.27$-0.15+44.4%$92.28M+4.0%
2025-03-31$-0.25$-0.11+56.0%$82.28M+5.5%
2024-12-31$-0.49$-0.24+51.0%$80.08M+5.5%
2024-09-30$-0.49$-0.25+49.0%$88.83M+5.8%
2024-06-30$-0.55$-0.24+56.4%$88.77M+6.1%
2024-03-31$-0.76$-0.62+18.4%$78.03M+8.1%
2023-12-31$-0.62$-1.14-83.9%$75.90M
2023-09-30$-0.49$-0.55-12.2%$83.97M
2023-06-30$-0.59$-0.42+28.8%$83.64M
2023-03-31$-0.81$-0.88-8.6%$72.16M
2022-12-31$-0.57$-0.20+64.9%

Frequently asked questions

Has Inogen Inc beaten earnings estimates?
Inogen Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +40.3% over the last 4 quarters.
How does INGN stock react to earnings?
INGN stock has moved an average of -5.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Inogen Inc's revenue growth rate?
Inogen Inc reported year-over-year revenue growth of +2.0% in its most recent quarter, with EPS growing +37.5% year-over-year.